Live Oak Investment Partners Bristol Myers Squibb CO Transaction History
Live Oak Investment Partners
- $116 Million
- Q2 2024
A detailed history of Live Oak Investment Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Live Oak Investment Partners holds 285 shares of BMY stock, worth $15,378. This represents 0.01% of its overall portfolio holdings.
Number of Shares
285
Previous 285
-0.0%
Holding current value
$15,378
Previous $14,000
21.43%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,407Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.56 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.93 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.03 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.19 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...